017–Safety and Efficacy of Somavaratan (VRS-317), a Long-Acting Growth Hormone, in Children with Growth Hormone Deficiency (GHD): 2.5-Year Results from the VISTA Trial
Leutjen, Terri, Di Trapani, Kelly, Ng, David, Humphriss, Eric, Charlton, WillVolume:
34
Language:
english
Journal:
Journal of Pediatric Nursing
DOI:
10.1016/j.pedn.2017.02.026
Date:
May, 2017
File:
PDF, 72 KB
english, 2017